4.7 Article

Negatively Charged Glyconanoparticles Modulate and Stabilize the Secondary Structures of a gp120 V3 Loop Peptide: Toward Fully Synthetic HIV Vaccine Candidates

Journal

BIOCONJUGATE CHEMISTRY
Volume 26, Issue 4, Pages 755-765

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.5b00077

Keywords

-

Funding

  1. MINECO [CTQ2011-27268, FIS PI12/00506]
  2. Department of Industry of the Basque Country [ETORTEK2011]
  3. FIPSE [360924/10]
  4. Spanish AIDS Research Network [RD12/0017/0015]
  5. ISCIII-Subdireccion General de Evaluacion and European Funding for Regional Development (FEDER)
  6. European Union (CHAARM) [Health-F3-2009-242135, AIM-HIV Health-F3-2012-305938]
  7. Cost Action [CM1102]
  8. Program EVA Centre for AIDS Reagents
  9. NIBSC HPA UK
  10. EC
  11. NGIN consortia
  12. Bill and Melinda Gates GHRC-CAVD Project [ARP683]
  13. monoclonal antibody 447-52D [ARP3219]
  14. V3 peptide [EVA7041]

Ask authors/readers for more resources

The third variable region (V3 peptide) of the HIV-1 gp120 is a major immunogenic domain of HIV-1. Controlling the formation of the immunologically active conformation is a crucial step to the rational design of fully synthetic candidate vaccines. Herein, we present the modulation and stabilization of either the alpha-helix or beta-strand conformation of the V3 peptide by conjugation to negatively charged gold glyconanoparticles (GNPs). The formation of the secondary structure can be triggered by the variation of the buffer concentration and/or pH as indicated by circular dichoism. The peptide on the GNPs shows increased stability toward peptidase degradation as compared to the free peptide. Moreover, only the V3 beta-GNPs bind to the anti-V3 human broadly neutralizing mAb 447-52D as demonstrated by surface plasmon resonance (SPR). The strong binding of V3 beta-GNPs to the 447-52D mAb was the starting point to address its study as immunogen. V3 beta-GNPs elicit antibodies in rabbits that recognize a recombinant gp120 and the serum displayed low but consistent neutralizing activity. These results open up the way for the design of new fully synthetic HIV vaccine candidates.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available